Brief: The Australian Natural Therapeutics Group Signs $7.8 Mln Product Agreement With Clever Leaves
28/02/2022 13:49
Feb 28 (Reuters) - Clever Leaves Holdings Inc CLVR.O :
* THE AUSTRALIAN NATURAL THERAPEUTICS GROUP SIGNS A US$7.8M
PRODUCT AGREEMENT WITH CLEVER LEAVES TO ACCELERATE MEDICAL
CANNABIS ACCESS IN AUSTRALIA
Source text for Eikon: ID:nGNX3BNPbS
Further company coverage: CLVR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Clever Leaves Holdings
See all newsBrief: Clever Leaves Holdings Provided Notice To Canaccord Genuity To Terminate Certain Equity Distribution Agreement
Brief: Clever Leaves Holdings' Unit Northern Swan Deutschland Entered Into First Share Purchase And Transfer Agreement
Brief: Clever Leaves Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Clever Leaves Says Colombian Flower Is Now Available To Australian Patients
Brief: Clever Leaves And Astrasana Partner To Establish International Supply Agreement For Medical Cannabis Extracts In Czech Republic And Switzerland